These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26671676)

  • 1. Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis.
    Schaub JA; Coca SG; Moledina DG; Gentry M; Testani JM; Parikh CR
    JACC Heart Fail; 2015 Dec; 3(12):977-89. PubMed ID: 26671676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal dysfunction and accuracy of N-terminal pro-B-type natriuretic peptide in predicting mortality for hospitalized patients with heart failure.
    Scrutinio D; Mastropasqua F; Guida P; Ammirati E; Ricci V; Raimondo R; Frigerio M; Lagioia R; Oliva F
    Circ J; 2014; 78(10):2439-46. PubMed ID: 25168191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].
    Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA
    Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
    Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease.
    Fu S; Luo L; Ye P; Yi S; Liu Y; Zhu B; Wang L; Xiao T; Bai Y
    Clin Interv Aging; 2013; 8():409-17. PubMed ID: 23723693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of renal function on the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with coronary artery disease.
    Chen F; Li JQ; Ou YW; Xia TL; Huang FY; Chai H; Huang BT; Li Q; Pu XB; Li GY; Peng Y; Chen M; Huang DJ
    Cardiol J; 2019; 26(6):696-703. PubMed ID: 29611168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial fibrosis combined with NT-proBNP improves the accuracy of survival prediction in ADHF patients.
    Yao Y; Feng L; Sun Y; Wang S; Sun J; Hu B
    BMC Cardiovasc Disord; 2021 May; 21(1):264. PubMed ID: 34049488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
    Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
    Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
    deFilippi CR; Seliger SL; Maynard S; Christenson RH
    Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.
    Cunningham JW; Vaduganathan M; Claggett BL; Zile MR; Anand IS; Packer M; Zannad F; Lam CSP; Janssens S; Jhund PS; Kober L; Rouleau J; Shah SJ; Chopra VK; Shi VC; Lefkowitz MP; Prescott MF; Pfeffer MA; McMurray JJV; Solomon SD
    JACC Heart Fail; 2020 May; 8(5):372-381. PubMed ID: 32241619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.
    Jafri L; Kashif W; Tai J; Siddiqui I; Azam I; Shahzad H; Ghani F
    BMC Nephrol; 2013 May; 14():117. PubMed ID: 23725445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.